Clinical Considerations for Routine Auditory and Vestibular Monitoring in Patients With Cystic Fibrosis.

ABSTRACT: Purpose Specific classes of antibiotics, such as aminoglycosides, have well-established adverse events producing permanent hearing loss, tinnitus, and balance and/or vestibular problems (i.e., ototoxicity). Although these antibiotics are frequently used to treat pseudomonas and other bacterial infections in patients with cystic fibrosis (CF), there are no formalized recommendations describing approaches to implementation of guideline adherent ototoxicity monitoring as part of CF clinical care. Method This consensus statement was developed by the International Ototoxicity Management Working Group (IOMG) Ad Hoc Committee on Aminoglycoside Antibiotics to address the clinical need for ototoxicity management in CF patients treated with known ototoxic medications. These clinical protocol

SUBMITTER: Garinis AC 

PROVIDER: S-EPMC9126110 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature